Saeid Safiri1,2,3, Ali Asghar Kolahi4, Marita Cross5, Kristin Carson-Chahhoud6, Amir Almasi-Hashiani7, Jay Kaufman8, Mohammad Ali Mansournia9, Mahdi Sepidarkish10, Ahad Ashrafi-Asgarabad11, Damian Hoy5, Gary Collins12, Anthony D Woolf13, Lyn March5, Emma Smith5. 1. Social Determinants of Health Research Center, Department of Community Medicine, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. 2. Sports Medicine Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. 3. Physical Medicine and Rehabilitation Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran. 4. Social Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 5. Institute of Bone and Joint Research, Kolling Institute, Faculty of Medicine and Health, The University of Sydney, St Leonards, New South Wales, Australia. 6. Australian Centre for Precision Health, School of Health Sciences, University of South Australia, Adelaide, South Australia, Australia. 7. Department of Epidemiology, School of Health, Arak University of Medical Sciences, Arak, Iran. 8. Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montreal, Quebec, Canada. 9. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. 10. Department of Biostatistics and Epidemiology, Babol University of Medical Sciences, Babol, Iran. 11. Department of Epidemiology, School of Health, Bam University of Medical Sciences, Bam, Iran. 12. Centre for Statistics in Medicine, NDORMS, Botnar Research Centre, University of Oxford, Oxford, UK. 13. Royal Cornwall Hospital and University of Exeter Medical School, Truro, UK.
Abstract
OBJECTIVES: To describe the level and trends of point prevalence, deaths and disability-adjusted life years (DALYs) for other musculoskeletal (MSK) disorders, i.e. those not covered by specific estimates generated for RA, OA, low back pain, neck pain and gout, from 1990 to 2017 by age, sex and sociodemographic index. METHODS: Publicly available modelled estimates from the Global Burden of Disease (GBD) 2017 study were extracted and reported as counts and age-standardized rates per 100 000 population for 195 countries and territories between 1990 and 2017. RESULTS: Globally, the age-standardized point prevalence estimates and deaths rates of other MSK disorders in 2017 were 4151.1 and 1.0 per 100 000. This was an increase of 3.4% and 7.2%, respectively. The age-standardized DALY rate in 2017 was 380.2, an increase of 3.4%. The point prevalence estimate was higher among females and increased with age. This peaked in the 65-69 year age group for both females and males in 2017, followed by a decreasing trend for both sexes. At the national level, the highest age-standardized point prevalence estimates in 2017 were seen in Bangladesh, India and Nepal. The largest increases in age-standardized point prevalence estimates were observed in Romania, Croatia and Armenia. CONCLUSION: The burden of other MSK disorders is proven to be substantial and increasing worldwide, with a notable intercountry variation. Data pertaining to specific diseases within this overarching category are required for future GBD MSK estimates. This would enable policymakers to better allocate resources and provide interventions appropriately.
OBJECTIVES: To describe the level and trends of point prevalence, deaths and disability-adjusted life years (DALYs) for other musculoskeletal (MSK) disorders, i.e. those not covered by specific estimates generated for RA, OA, low back pain, neck pain and gout, from 1990 to 2017 by age, sex and sociodemographic index. METHODS: Publicly available modelled estimates from the Global Burden of Disease (GBD) 2017 study were extracted and reported as counts and age-standardized rates per 100 000 population for 195 countries and territories between 1990 and 2017. RESULTS: Globally, the age-standardized point prevalence estimates and deaths rates of other MSK disorders in 2017 were 4151.1 and 1.0 per 100 000. This was an increase of 3.4% and 7.2%, respectively. The age-standardized DALY rate in 2017 was 380.2, an increase of 3.4%. The point prevalence estimate was higher among females and increased with age. This peaked in the 65-69 year age group for both females and males in 2017, followed by a decreasing trend for both sexes. At the national level, the highest age-standardized point prevalence estimates in 2017 were seen in Bangladesh, India and Nepal. The largest increases in age-standardized point prevalence estimates were observed in Romania, Croatia and Armenia. CONCLUSION: The burden of other MSK disorders is proven to be substantial and increasing worldwide, with a notable intercountry variation. Data pertaining to specific diseases within this overarching category are required for future GBD MSK estimates. This would enable policymakers to better allocate resources and provide interventions appropriately.
Authors: Sinisa Stefanac; Claudia Oppenauer; Michael Zauner; Martina Durechova; Daffodil Dioso; Daniel Aletaha; Gerhard Hobusch; Reinhard Windhager; Tanja Stamm Journal: Ann Med Date: 2022-12 Impact factor: 5.348
Authors: César Calvo-Lobo; Ricardo Becerro-de-Bengoa-Vallejo; Marta Elena Losa-Iglesias; David Rodríguez-Sanz; Daniel López-López; Marta San-Antolín Journal: Nutrients Date: 2021-01-20 Impact factor: 5.717
Authors: Katie de Luca; Andrew M Briggs; Simon D French; Manuela L Ferreira; Marita Cross; Fiona Blyth; Lyn March Journal: Chiropr Man Therap Date: 2022-05-03